Clinical Trial Update: Levonorgestrel-releasing Intrauterine System Versus a Low-dose Combined Oral Contraceptive for Management of Adenomyosis Uteri [EARLY_Phase 1]

View source ↗

Summary

A clinical trial comparing the levonorgestrel-releasing intrauterine system with a low-dose combined oral contraceptive for the management of adenomyosis uteri;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenomyosis

Drugs mentioned

• Levonorgestrel-releasing intrauterine system (LNG-IUS) (Levonorgestrel-releasing intrauterine system)
• Low-dose combined oral contraceptive (combined oral contraceptive)

Snippet

Sponsor: Ain Shams Maternity Hospital | Conditions: Adenomyosis | EARLY_Phase 1 | Status: UNKNOWN